Jgsbiopharma Limited
08801963
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 04/12/2013
INVESTMENT DIRECTOR
BRITISH · UNITED KINGDOM · Age 71
Persons with Significant Control
Catherine Shields
British · England · Age 70
10, Wellington Street, Cambridge, CB1 1HW
Notified 06/04/2016
Dr John Gerard Shields
British · England · Age 71
10, Wellington Street, Cambridge, CB1 1HW
Notified 19/12/2025
Former PSCs
Dr John Gerard Shields
Ceased 18/12/2025
CompanyRankvs 9435+ SIC 70229 peers80
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£61k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£63k
Working capital
Current Assets
£67k
Current Liabilities
£3k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 20.79 | -£53k |
| 2023 | 41.22 | -£53k |
| 2022 | 76.65 | -£82k |
| 2021 | 11.74 | +£26k |
| 2020 | 11.69 | +£13k |
| 2019 | 6.15 | +£25k |
| 2018 | 5.35 | — |
Derived from filed accounts. Not audited figures.